Using Apple Vision Pro in image-guided procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study explores the use of Apple Vision Pro technology during CT-guided biopsy procedures. Primary operators complete post-procedure surveys to assess usability, ergonomics, and spatial awareness while performing the procedures. The study collects survey data from attending interventional radiologists who have completed required training, focusing on hands-on experiences and perceived aids or barriers in spatial computing during image-guided biopsies of the abdomen or pelvis. No randomized interventions or additional procedures are introduced beyond standard CT-guided biopsy practice. The research is conducted at UT MD Anderson Cancer Center, with MD Anderson as the lead sponsor.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Participants:

• 18-years-old and older, any sex, race, or ethnicity, undergoing CT-guided biopsy of the abdomen or pelvis.

Primary operators:

• Attending physicians in Interventional Radiology who have completed mandatory training and familiarization.

Exclusion Criteria:

• Participants unable to provide informed consent or contraindications to planned procedures.

Where it's running

• UT MD Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Aaron K Jones, MD — UT MD Anderson Cancer Center
• Study coordinator: Aaron K Jones, MD
• Email: Kyle.Jones@mdanderson.org
• Phone: 713-563-0552

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Preventing heart problems in overweight/obese young sarcoma survivors with tirzepatide

  This feasibility study tests whether tirzepatide can be safely given to overweight or obese young adults (18–39) who have completed doxorubicin for soft tissue or bone sarcoma to see if it’s feasible to use in the first year after therapy.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT07874828

• Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis

  This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07855627

• Precision genomic testing to guide first-line LBCL treatment readiness

  Doctors will see if a tumor genomic test can help tailor first-line treatment for adults with LBCL by the start of the second cycle of standard therapy.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07829445

• Geniculate Artery Embolization for Knee Osteoarthritis in Cancer Patients

  This study tests whether blocking knee blood vessels with a standard care procedure can help reduce pain and improve function in people with knee osteoarthritis who also have cancer.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07807943

• Urothelial Carcinoma Biospecimen Collection and Data Study

  This project tests collecting and storing tissue, blood, and imaging data from adults with urothelial carcinoma to support translational research.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07789119

• Chatbot support for informed consent in research

  A chatbot named CoCo is tested to see if it can help patients understand and feel satisfied with the consent process for research studies.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07756515

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.